Application no. and date | 12848968.9 (espacenet) (Federated) (European Patent Register), 20121114 | Patent/reg. no. and date | DK/EP 2780022, 20190605 | Publication date | 20140924 | Priority no. and date | US 201161559521 P, 20111114, US 201261589741 P, 20120123, US 201261724047 P, 20121108 | EP pub. no. and date |
EP 2780022 20140924 | Effective date | | Applicant/owner | Astellas Institute for Regenerative Medicine, 33 Locke Drive
Marlborough, MA 01752, US | Applicant ref. no. | P68813DK01 | Inventor | LANZA, Robert, 35 South Meadow Road
Clinton, Massachusetts 01510, US, KLIMANSKAYA, Irina, 75 Mechanic Street
Upton, Massachusetts 01568, US, GAY, Roger, 18 Wiley Road
Belmont, Massachusetts 02478, US | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | Astellas Institute for Regenerative Medicine, 33 Locke Drive
Marlborough, MA 01752, US | IPC Class | A61K 35/12 (2015.01) , A61K 35/44 (2015.01) , A61K 35/50 (2015.01) , A61P 27/02 (2006.01) , C12N 5/095 (2010.01) | Title | FARMACEUTISKE PRÆPARATER AF HUMANE RPE-CELLER OG ANVENDELSER DERAF | Int. application no. | US2012065091 | Int. publication no. | WO2013074681 | Related patent (certificate) | | Status | Ændret DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|